Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder

NCT06810310 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06810310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Recruiting
Start date
December 22, 2025
Completion date
May 1, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder